Holen Sie sich die Stockscreener-App
37.71
0.89%
-0.34
Schlusskurs vom Vortag:
$38.05
Offen:
$38.84
24-Stunden-Volumen:
395.45K
Relative Volume:
0.97
Marktkapitalisierung:
$1.76B
Einnahmen:
$45.95M
Nettoeinkommen (Verlust:
$-48.88M
KGV:
-33.88
EPS:
-1.1129
Netto-Cashflow:
$109.67M
1W Leistung:
-0.16%
1M Leistung:
+0.56%
6M Leistung:
+49.76%
1J Leistung:
+87.15%
1-Tages-Spanne:
$37.31
$39.10
1-Wochen-Bereich:
$37.03
$39.85
52-Wochen-Spanne:
$17.55
$51.10
Septerna Inc Stock (SEPN) Company Profile
Firmenname
Septerna Inc
Sektor
Branche
Telefon
650-338-3533
Adresse
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Compare SEPN vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
37.71 | 1.76B | 45.95M | -48.88M | 109.67M | -1.1129 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-19 | Eingeleitet | Raymond James | Strong Buy |
| 2025-12-15 | Eingeleitet | Truist | Buy |
| 2025-11-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-02-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-19 | Eingeleitet | TD Cowen | Buy |
| 2024-11-19 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Septerna Inc Aktie (SEPN) Neueste Nachrichten
Officer Daniel Long proposes selling 10,001 Septerna (SEPN) common shares. - Stock Titan
Septerna, Inc. (SEPN) Investor Outlook: Strong Buy Ratings Signal 37% Potential Upside - DirectorsTalk Interviews
Septerna, Inc.Common Stock (NQ: SEPN - The Chronicle-Journal
Septerna (SEPN) Heads To Healthcare Conferences, Is The Valuation Already Too Rich? - Yahoo Finance
Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Septerna's CMO Rajiv Patni Granted 275,000 Stock Options with 10-Year Expiry - Kalkine Media
Septerna (SEPN) awards CMO 275,000 options at $37.37 - Stock Titan
Septerna Announces Inducement Grant Under Nasdaq Listing Rule - TradingView
A new medical chief gets an option to buy up to 275,000 Septerna shares at $37.37 - Stock Titan
Wells Fargo Sticks to Their Buy Rating for Septerna, Inc. (SEPN) - The Globe and Mail
Septerna at Cantor Fitzgerald conference: pipeline broadens, cash holds - Investing.com
Septerna at Cantor Fitzgerald conference: pipeline broadens, cash holds By Investing.com - Investing.com Canada
Septerna (SEPN) Q2 2026 Earnings: $0.29 Per-Share Loss Beats Estimates by 33.26% as Stock Gains 3.28%ROIC Trend Report - dars.gov.et
Septerna at Wells Fargo conference: platform bets and pipeline catalysts By Investing.com - Investing.com Canada
Septerna SVP Daniel Long sells $126,077 in company stock By Investing.com - Investing.com South Africa
Septerna SVP Daniel Long sells $126,077 in company stock - investing.com
New Septerna (SEPN) chief medical officer reports zero share holdings - Stock Titan
Septerna to Participate in Upcoming Investor Conferences - manilatimes.net
Septerna (SEPN) Declines 1.95% to $38.15, Approaching Key Support at $36.24Parabolic SAR - vinanet.vn
Septerna Inc Q2 Income From Operations USD -1 - moomoo.com
Septerna (SEPN) Is Down 7.1% After Broad Russell Index Additions Has The Bull Case Changed? - sahmcapital.com
Septerna stock soars 315% on Novo Nordisk deal and key drug milestones - Pluang
Septerna appoints Rajiv Patni as chief medical officer By Investing.com - Investing.com Canada
Septerna Appoints Rajiv Patni as Chief Medical Officer - TipRanks
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer - The Manila Times
Septerna (SEPN) Results at a Glance: The Bottom-Line Figure Outpaces Its Comparison in the Latest Reading; Market Response: The Share Price Adds 1.30% in the Latest SessionMargin Guidance - dars.gov.et
Septerna (SEPN) Shares: Finishes 2.10% Higher at $40.84 for the Current Session; Immediate View: Support at $38.80 and Resistance at $42.88 Frame the Range in Latest TradingStandard Deviation - vinanet.vn
Driehaus Capital Management Expands Septerna Inc (SEPN) Stake in Second Quarter - GuruFocus
Septerna (NASDAQ:SEPN) Stock Price Down 8%Time to Sell? - MarketBeat
Analysts Offer Insights on NA Companies: Cerebras Systems, Inc. Class A (CBRS), Septerna, Inc. (SEPN) and TWFG, Inc. Class A (TWFG) - theglobeandmail.com
SEPN Maintained by JP Morgan -- Price Target Raised to $48 - GuruFocus
Septerna (NASDAQ:SEPN) Price Target Raised to $48.00 - MarketBeat
J.P. Morgan Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $48 - Moomoo
SEPTERNA, INC. : JP MORGAN RAISES TARGET PRICE TO $48 FROM $38 - Bitget
4,211,659 Shares in Septerna, Inc. $SEPN Acquired by Trv Gp Vi LLC - MarketBeat
Trv Gp V LLC Takes Position in Septerna, Inc. $SEPN - MarketBeat
Septerna, Inc. SEPN Stock Forecast & Price Target - Yahoo Finance
Septerna, Inc. (SEPN) Receives a Rating Update from a Top Analyst - The Globe and Mail
37,700 Shares in Septerna, Inc. $SEPN Purchased by Renaissance Technologies LLC - MarketBeat
Ra Capital Management sells $63.45m in Septerna stock By Investing.com - Investing.com Australia
Ra Capital Management sells $63.45m in Septerna stock - Investing.com
Septerna(SEPN.US) 10% Shareholder Sells US$7.4 Million in Common Stock - Moomoo
Third Rock Ventures V, L.P. director sells $7.4m Septerna shares - Investing.com South Africa
RA Capital Management Offloads 1.49 Million Septerna Shares at $42.50 Each - Kalkine Media
Septerna (SEPN): RA Capital funds disclose sale of 1.49M common shares - Stock Titan
Form 4: Third Rock Ventures reports acquisition/exercise transactions in SEPN - Stock Titan
RA Capital group (SEPN) discloses 11.8% Septerna stake and major block sales - Stock Titan
HC Wainwright Predicts Septerna's Q3 Earnings (NASDAQ:SEPN) - MarketBeat
Driehaus Capital Management (SEPN) discloses 4.43M-share Septerna stake in 13G/A - Stock Titan
Finanzdaten der Septerna Inc-Aktie (SEPN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):